| RS763294619 |
PACS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, PACS1-related disorder |
| RS763294691 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS763295314 |
IMPG2
|
Health Risk |
Pathogenic |
Vitelliform macular dystrophy 5, Autosomal recessive retinitis pigmentosa |
| RS763295786 |
AFF4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome, Inborn genetic diseases |
| RS763295904 |
SEMA3E
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, SEMA3E-related disorder |
| RS763295910 |
RNASET2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic leukoencephalopathy without megalencephaly, Cystic leukoencephalopathy without megalencephaly |
| RS763295984 |
NIPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 6, Hereditary spastic paraplegia 6 |
| RS763296134 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS763296454 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS763296857 |
SRD5A2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency, 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency |
| RS763298490 |
PC
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate carboxylase deficiency, PC-related disorder |
| RS763298510 |
SLC22A12
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Dalmatian hypouricemia |
| RS763298811 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS763299645 |
NAGLU
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS763299839 |
DST
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 3, localized or generalized intermediate |
| RS763299856 |
WDPCP
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS763299873 |
BMP1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 13, Osteogenesis imperfecta type 13 |
| RS763299947 |
DCDC2
|
Health Risk |
Pathogenic |
DCDC2-related disorder, DCDC2-related disorder |
| RS763300393 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis 3, Nephronophthisis |
| RS763300541 |
GCDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Glutaric aciduria, type 1 |
| RS763301021 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS763301606 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS763301637 |
HGSNAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Mucopolysaccharidosis |
| RS763302311 |
GBE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type IV |
| RS763302328 |
TRMT1
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal recessive 68 |
| RS763302555 |
TRPV4
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2C, Neuronopathy |
| RS763302590 |
FGFR3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS763303046 |
DLD
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS763303290 |
PKP2
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular dysplasia 9, Arrhythmogenic right ventricular dysplasia 9 |
| RS763303967 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS763305108 |
HPS3
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS763305896 |
NT5C2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 45, Hereditary spastic paraplegia 45 |
| RS763306448 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS763307794 |
CFAP300
|
Health Risk |
Pathogenic |
— |
| RS763308199 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS763308607 |
PMS2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 4 |
| RS763309812 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS763310793 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS763310804 |
NEK1
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 6 with or without polydactyly, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS763311061 |
COQ8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS763312940 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS763313220 |
BMPR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS763314828 |
PSMB8
|
Health Risk |
Likely pathogenic |
Proteasome-associated autoinflammatory syndrome 1, Proteasome-associated autoinflammatory syndrome 1 |
| RS763315364 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS763315862 |
ERCC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Xeroderma pigmentosum group B, Inborn genetic diseases |
| RS763316592 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS763317358 |
NCF2
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS763317497 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS763320093 |
LMX1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Sensorineural hearing loss disorder, Autosomal-Recessive Hereditary Hearing Impairment |
| RS763320493 |
MACF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS763321913 |
SMARCD2
|
Health Risk |
Pathogenic |
— |
| RS763321998 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS763323157 |
SUN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy, Emery-Dreifuss muscular dystrophy |
| RS763323368 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 |
| RS763324017 |
SUCLG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 9, Mitochondrial DNA depletion syndrome 9 |
| RS763324083 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS763324131 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS763324776 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS763325410 |
SYNE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS763325435 |
NMNAT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 9, Leber congenital amaurosis 9 |
| RS763326062 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS763326505 |
SOX4
|
Health Risk |
Likely pathogenic |
— |
| RS763326515 |
TBXAS1
|
Health Risk |
Pathogenic |
Ghosal hematodiaphyseal dysplasia, Ghosal hematodiaphyseal dysplasia |
| RS763328506 |
ALOX12B
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 2, Lamellar ichthyosis |
| RS763329139 |
TCF4
|
Health Risk |
Conflicting classifications of pathogenicity |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS763330257 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS763330423 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Primary dilated cardiomyopathy |
| RS763330792 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia 1 |
| RS763330900 |
ADAMTS18
|
Health Risk |
Pathogenic |
— |
| RS763331671 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS763331925 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 25, Inborn genetic diseases |
| RS763332557 |
MYL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy 10 |
| RS763332823 |
PBX1
|
Health Risk |
Pathogenic |
— |
| RS763332859 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS763333048 |
NPHP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Nephronophthisis |
| RS763333945 |
HADHB
|
Health Risk |
Pathogenic |
Mitochondrial trifunctional protein deficiency, Mitochondrial trifunctional protein deficiency |
| RS763336139 |
EGF
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal hypomagnesemia 4, EGF-related disorder |
| RS763336230 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset myopathy with fatal cardiomyopathy, Myopathy |
| RS763336891 |
CR2
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS763336898 |
DNMT3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Tatton-Brown-Rahman overgrowth syndrome, Tatton-Brown-Rahman overgrowth syndrome |
| RS763337272 |
YARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease dominant intermediate C, Inborn genetic diseases |
| RS763339068 |
HCN1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS763339686 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
CFTR-related disorder, Cystic fibrosis |
| RS763342449 |
SI
|
Health Risk |
Pathogenic |
— |
| RS763342949 |
DOCK7
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 23 |
| RS763343306 |
UNC13D
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS763343344 |
DAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2P, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS763343580 |
AFG2B
|
Health Risk |
Pathogenic |
Hearing loss, autosomal recessive 119 |
| RS763344375 |
THOC6
|
Health Risk |
Pathogenic |
Inborn genetic diseases, THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome |
| RS763344414 |
GFM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS763344951 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS763345078 |
CEP290
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 14, Meckel syndrome |
| RS763346457 |
PEPD
|
Health Risk |
Conflicting classifications of pathogenicity |
Prolidase deficiency, Prolidase deficiency |
| RS763346690 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS763347763 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Kabuki syndrome |
| RS763348222 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS763349669 |
DIAPH1
|
Health Risk |
Likely pathogenic |
Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome, Autosomal dominant nonsyndromic hearing loss 1 |
| RS763349891 |
PYCR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive cutis laxa type 2B, PYCR1-related de Barsy syndrome |
| RS763350185 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS763351805 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |